Literature DB >> 19769013

The impact of race and ethnicity on disease severity in systemic lupus erythematosus.

Katie L Crosslin1, Kristin L Wiginton.   

Abstract

OBJECTIVES: Systemic lupus erythematosus (SLE) can result in comorbidities and high disease severity. The aim of this study was to evaluate the effects of age, sex, race, ethnicity, cost of hospitalization, length of stay, and payor source on SLE disease severity scores.
DESIGN: Epidemiological study.
SETTING: Hospital discharge data were obtained from the DFW Hospital Council (DFWHC), for 65,535 patients hospitalized in the North Texas Dallas-Fort Worth (DFW) Metropolitan Statistical Area (MSA) from 1999-2005 with at least one autoimmune disease. PATIENTS: Of the 65,535 autoimmune patients, 14,829 patients had SLE as a diagnosis. The sample was assessed for disease severity according to the SLE comorbidity Index. MAIN OUTCOME: Disease severity, SLE comorbidities.
RESULTS: SLE patients were younger and more than five times more likely to have multiple autoimmune diseases. More than one third of Hispanic patients were on Medicaid or self-pay and more likely to have higher disease severity. Race (Caucasian), sex (female), and payor source (PPO/POS) predicted lower disease severity scores. SLE was predictive of eight of the fourteen SLE-CI diseases, with greatest effects observed for nephritis (OR = 3.30, P < .0001), chronic renal failure (OR = 3.36, P < .0001), pericarditis (OR = 3.2, P < .0001), and pleuritis (OR = 2.06, P < .0001). Non-Caucasian patients were more likely to have chronic renal failure, nephritis, congestive heart failure, pericarditis and pleuritis.
CONCLUSIONS: The comorbidities that exist in SLE vary according to ethnicity. It is paramount for physicians to be cognizant of these disparities and make appropriate referrals.

Entities:  

Mesh:

Year:  2009        PMID: 19769013

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  9 in total

1.  Characterization of autosomal copy-number variation in African Americans: the HyperGEN Study.

Authors:  Nathan E Wineinger; Nicholas M Pajewski; Richard E Kennedy; Mary K Wojczynski; Laura K Vaughan; Steven C Hunt; C Charles Gu; Dabeeru C Rao; Rachel Lorier; Ulrich Broeckel; Donna K Arnett; Hemant K Tiwari
Journal:  Eur J Hum Genet       Date:  2011-06-15       Impact factor: 4.246

2.  Disease Outcomes and Care Fragmentation Among Patients With Systemic Lupus Erythematosus.

Authors:  Theresa L Walunas; Kathryn L Jackson; Anh H Chung; Karen A Mancera-Cuevas; Daniel L Erickson; Rosalind Ramsey-Goldman; Abel Kho
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-08-08       Impact factor: 4.794

3.  Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients.

Authors:  Ryan Webb; Jennifer A Kelly; Emily C Somers; Travis Hughes; Kenneth M Kaufman; Elena Sanchez; Swapan K Nath; Gail Bruner; Marta E Alarcón-Riquelme; Gary S Gilkeson; Diane L Kamen; Bruce C Richardson; John B Harley; Amr H Sawalha
Journal:  Ann Rheum Dis       Date:  2010-09-29       Impact factor: 19.103

Review 4.  Disease-Specific Health Disparities: A Targeted Review Focusing on Race and Ethnicity.

Authors:  Mark R Cullen; Adina R Lemeshow; Leo J Russo; David M Barnes; Yaa Ababio; Aida Habtezion
Journal:  Healthcare (Basel)       Date:  2022-03-23

5.  Race/ethnicity is an independent risk factor for autoimmune hepatitis among the San Francisco underserved.

Authors:  Briton Lee; Edward W Holt; Robert J Wong; Justin L Sewell; Ma Somsouk; Mandana Khalili; Jacquelyn J Maher; Michele M Tana
Journal:  Autoimmunity       Date:  2018-06-11       Impact factor: 2.815

6.  Characteristics of comorbidities and costs among patients who died from systemic lupus erythematosus in Taiwan.

Authors:  Shih-Chao Kang; Shinn-Jang Hwang; Yu-Sheng Chang; Chung-Tei Chou; Chang-Youh Tsai
Journal:  Arch Med Sci       Date:  2012-09-08       Impact factor: 3.318

7.  Are ethnicity, social grade, and social deprivation associated with severity of thyroid-associated ophthalmopathy?

Authors:  Matthew R Edmunds; Julie A Huntbach; Omar M Durrani
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2014 May-Jun       Impact factor: 1.746

8.  The risk of end-stage renal disease in systemic lupus erythematosus: A nationwide population-based study in Korea.

Authors:  Hong Sang Choi; Kyung-Do Han; Jin-Hyung Jung; Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

9.  Cell-bound complement activation products associate with lupus severity in SLE.

Authors:  Cristina Arriens; Roberta Vezza Alexander; Sonali Narain; Amit Saxena; Christopher E Collins; Daniel J Wallace; Elena Massarotti; John Conklin; Kenneth C Kalunian; Chaim Putterman; Rosalind Ramsey-Goldman; Jill P Buyon; Anca Askanase; Richard A Furie; Judith A James; Ghalib A Bello; Susan Manzi; Joseph Ahearn; Tyler O'Malley; Arthur Weinstein; Thierry Dervieux
Journal:  Lupus Sci Med       Date:  2020-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.